Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,865 | 41,360 | 46,134 | 16,946 | 14,723 |
| Marketable Securities | 921 | N/A | N/A | N/A | N/A |
| Receivables | 2,510 | 1,888 | 1,861 | 1,395 | 702 |
| Inventories | 2,033 | 1,476 | N/A | 529 | 32 |
| Income taxes - deferred | N/A | N/A | 1,270 | N/A | N/A |
| Other current assets | 2,525 | 1,833 | 1,562 | 1,467 | 993 |
| TOTAL | $40,854 | $46,556 | $50,827 | $20,337 | $16,449 |
| Non-Current Assets | |||||
| PPE Net | 15,639 | 13,791 | 12,844 | 11,332 | 10,874 |
| Intangibles | 75,443 | 24,842 | 24,993 | 25,145 | 25,296 |
| Other Non-Current Assets | 1,460 | 1,205 | 1,152 | 973 | 991 |
| TOTAL | $92,542 | $39,838 | $38,989 | $37,450 | $37,161 |
| Total Assets | $133,396 | $86,394 | $89,816 | $57,786 | $53,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,700 | 3,512 | 3,568 | 6,380 | 5,756 |
| Accrued Expenses | 2,587 | 2,382 | 4,018 | 2,232 | 1,989 |
| Other current liabilities | 2,831 | 2,056 | 1,840 | 1,022 | 362 |
| TOTAL | $11,912 | $8,786 | $9,807 | $10,036 | $8,385 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 348 | 220 |
| Other Non-Current Liabilities | 25,368 | 14,262 | 13,788 | 8,382 | 8,016 |
| TOTAL | $44,186 | $18,541 | $17,983 | $12,616 | $12,233 |
| Total Liabilities | $56,099 | $27,327 | $27,790 | $22,652 | $20,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 235 | 227 | 191 | 181 | 136 |
| Common Shares | 35 | 29 | 27 | 21 | 20 |
| Retained earnings | -262,661 | -250,056 | -236,374 | -223,839 | -214,768 |
| Other shareholders' equity | -447 | -283 | -222 | -260 | -137 |
| TOTAL | $77,297 | $59,067 | $62,026 | $35,134 | $32,992 |
| Total Liabilities And Equity | $133,396 | $86,394 | $89,816 | $57,786 | $53,610 |